Quarterly report pursuant to Section 13 or 15(d)

Supplemental Balance Sheet Information

v3.24.1.1.u2
Supplemental Balance Sheet Information
3 Months Ended
Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Supplemental Balance Sheet Information
7.
Supplemental Balance Sheet Information

Accrued expenses and other current liabilities consist of the following:

 

 

 

March 31,
2024

 

 

December 31,
2023

 

Accrued consulting

 

$

68,460

 

 

$

49,395

 

Accrued compensation

 

 

325,059

 

 

 

635,451

 

Accrued research and development

 

 

2,088,509

 

 

 

1,472,292

 

Accrued other

 

 

25,561

 

 

 

102,817

 

Total accrued expenses and other current liabilities

 

$

2,507,589

 

 

$

2,259,955